These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 1753978)
61. Data silos impede progress against prescription drug abuse. Traynor K Am J Health Syst Pharm; 2012 Apr; 69(8):628, 630, 632. PubMed ID: 22472861 [No Abstract] [Full Text] [Related]
62. The Prescription Drug Misuse Epidemic: Are We Making Progress? McClure FL Occup Health Saf; 2015 Sep; 84(9):88, 90, 92 passim. PubMed ID: 26495628 [No Abstract] [Full Text] [Related]
63. The politics of Ecstasy. Grob CS J Psychoactive Drugs; 2002; 34(2):143-4. PubMed ID: 12691204 [No Abstract] [Full Text] [Related]
64. Abuse liability and the regulatory control of therapeutic drugs: untested assumptions. Woods JH Drug Alcohol Depend; 1990 Apr; 25(2):229-33. PubMed ID: 1970287 [No Abstract] [Full Text] [Related]
65. Treatment of drug dependence in the context of traditional disease treatment models. Merrill JC; Menza M Psychiatr Serv; 2002 Dec; 53(12):1632-3. PubMed ID: 12461229 [No Abstract] [Full Text] [Related]
66. Prescription Drug Abuse Task Force recommendations. Prescription Drug Abuse Task Force J Ky Med Assoc; 2003 Nov; 101(11):495-7. PubMed ID: 14635577 [No Abstract] [Full Text] [Related]
67. Drug abuse: guest editorial. Smith D Clin Toxicol; 1970 Mar; 3(1):11-2. PubMed ID: 5520385 [No Abstract] [Full Text] [Related]
68. The harmfulness tax: a new approach to drug control. Grinspoon L; Bakalar JB Hosp Community Psychiatry; 1990 May; 41(5):483. PubMed ID: 2347567 [No Abstract] [Full Text] [Related]
69. Hindsight and new data converge on drug policy. Cotton P JAMA; 1994 Oct; 272(13):992-3. PubMed ID: 8089897 [No Abstract] [Full Text] [Related]
71. The lure of masterstrokes: drug legalization. Farell M; Strang J Br J Addict; 1990 Jan; 85(1):5-7. PubMed ID: 2310854 [No Abstract] [Full Text] [Related]
72. An uneasy alliance: combining qualitative and quantitative research methods. Buchanan DR Health Educ Q; 1992; 19(1):117-35. PubMed ID: 1568871 [TBL] [Abstract][Full Text] [Related]
73. The disease analogy and substance abuse. Scott M Psychiatr Serv; 2004 Jun; 55(6):720; author reply 720. PubMed ID: 15175477 [No Abstract] [Full Text] [Related]
74. [Action of the police in the field of drugs. Organizational problems: resolution of the uncertainty]. Manning PK Quad Criminol Clin; 1977; 19(2):137-96. PubMed ID: 897058 [No Abstract] [Full Text] [Related]
75. Ecstasy abuse and control: hearing before the Senate Subcommittee on Governmental Affairs--July 30, 2001. Statement for the record. Leshner AI J Psychoactive Drugs; 2002; 34(2):133-5. PubMed ID: 12691202 [No Abstract] [Full Text] [Related]
76. Methamphetamine: tools and partnerships to fight the threat. Chamberlain J; McDonald S; Torgensen K J Law Med Ethics; 2004; 32(4 Suppl):104-5. PubMed ID: 15807341 [No Abstract] [Full Text] [Related]
77. Drug abuse strategies. Martin WR Drug Alcohol Depend; 1990 Apr; 25(2):115-9. PubMed ID: 2328650 [No Abstract] [Full Text] [Related]
78. Drug laws. Article drifted into counterpropoganda. MacQueen AR BMJ; 2001 Oct; 323(7317):866-7. PubMed ID: 11683159 [No Abstract] [Full Text] [Related]
79. Substance abuse. Now, and for some time to come. Ward CF Anesthesiology; 1992 Oct; 77(4):619-22. PubMed ID: 1416157 [No Abstract] [Full Text] [Related]
80. Pentazocine abuse rises--Schedule IV status proposed. FDA Drug Bull; 1978 Dec-1979 Jan; 8(6):34. PubMed ID: 720788 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]